Cargando…

Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial

BACKGROUND: In reality, pharmacotherapy still remains the most common treatment for insomnia. OBJECTIVE: This study aimed to examine the effectiveness of our internet-delivered computerized cognitive behavioral therapy (ICBT) program as an adjunct to usual care (UC) compared with UC alone in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Sato, Daisuke, Yoshinaga, Naoki, Nagai, Eiichi, Nagai, Kazue, Shimizu, Eiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482403/
https://www.ncbi.nlm.nih.gov/pubmed/30973344
http://dx.doi.org/10.2196/12686
_version_ 1783413880198791168
author Sato, Daisuke
Yoshinaga, Naoki
Nagai, Eiichi
Nagai, Kazue
Shimizu, Eiji
author_facet Sato, Daisuke
Yoshinaga, Naoki
Nagai, Eiichi
Nagai, Kazue
Shimizu, Eiji
author_sort Sato, Daisuke
collection PubMed
description BACKGROUND: In reality, pharmacotherapy still remains the most common treatment for insomnia. OBJECTIVE: This study aimed to examine the effectiveness of our internet-delivered computerized cognitive behavioral therapy (ICBT) program as an adjunct to usual care (UC) compared with UC alone in patients with insomnia who remain symptomatic following hypnotics. METHODS: We recruited 23 patients with insomnia who remained symptomatic following pharmacologic treatment including benzodiazepines, and we conducted an exploratory randomized controlled trial. The primary outcome was the Pittsburgh Sleep Quality Index (PSQI) at week 6 of the treatment. Secondary outcomes were sleep onset latency, total sleep time, sleep efficiency, number of awakenings, refreshment and soundness of sleep, anxiety by Hospital Anxiety and Depression Scale, depression measured by the Center for Epidemiologic Studies Depression Scale, and quality of life (QOL) measured by the EuroQol-5D. All parameters were measured at weeks 0 (baseline), 6 (postintervention), and 12 (follow-up). RESULTS: The adjusted mean reduction (−6.11) in PSQI at week 6 from baseline in the ICBT plus UC group was significantly (P<.001) larger than the adjusted mean reduction (0.40) in the UC alone group. Significant differences were also found in favor of ICBT plus UC for PSQI, sleep onset latency, sleep efficiency, number of awakenings, and depression at all assessment points. Refreshment, soundness of sleep, anxiety, and QOL improved by week 6 in ICBT plus UC compared with UC alone. There were no reports of adverse events in either group during the study. CONCLUSIONS: These results indicated that our 6-week ICBT program is an effective treatment adjunct to UC for improving insomnia and related symptoms even after unsuccessful pharmacotherapy. TRIAL REGISTRATION: University Hospital Medical Information Network Clinical Trials Registry: UMIN000021509; https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023545 (Archived by WebCite at http://www.webcitation. org/75tCmwnYt).
format Online
Article
Text
id pubmed-6482403
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-64824032019-05-08 Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial Sato, Daisuke Yoshinaga, Naoki Nagai, Eiichi Nagai, Kazue Shimizu, Eiji J Med Internet Res Original Paper BACKGROUND: In reality, pharmacotherapy still remains the most common treatment for insomnia. OBJECTIVE: This study aimed to examine the effectiveness of our internet-delivered computerized cognitive behavioral therapy (ICBT) program as an adjunct to usual care (UC) compared with UC alone in patients with insomnia who remain symptomatic following hypnotics. METHODS: We recruited 23 patients with insomnia who remained symptomatic following pharmacologic treatment including benzodiazepines, and we conducted an exploratory randomized controlled trial. The primary outcome was the Pittsburgh Sleep Quality Index (PSQI) at week 6 of the treatment. Secondary outcomes were sleep onset latency, total sleep time, sleep efficiency, number of awakenings, refreshment and soundness of sleep, anxiety by Hospital Anxiety and Depression Scale, depression measured by the Center for Epidemiologic Studies Depression Scale, and quality of life (QOL) measured by the EuroQol-5D. All parameters were measured at weeks 0 (baseline), 6 (postintervention), and 12 (follow-up). RESULTS: The adjusted mean reduction (−6.11) in PSQI at week 6 from baseline in the ICBT plus UC group was significantly (P<.001) larger than the adjusted mean reduction (0.40) in the UC alone group. Significant differences were also found in favor of ICBT plus UC for PSQI, sleep onset latency, sleep efficiency, number of awakenings, and depression at all assessment points. Refreshment, soundness of sleep, anxiety, and QOL improved by week 6 in ICBT plus UC compared with UC alone. There were no reports of adverse events in either group during the study. CONCLUSIONS: These results indicated that our 6-week ICBT program is an effective treatment adjunct to UC for improving insomnia and related symptoms even after unsuccessful pharmacotherapy. TRIAL REGISTRATION: University Hospital Medical Information Network Clinical Trials Registry: UMIN000021509; https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023545 (Archived by WebCite at http://www.webcitation. org/75tCmwnYt). JMIR Publications 2019-04-11 /pmc/articles/PMC6482403/ /pubmed/30973344 http://dx.doi.org/10.2196/12686 Text en ©Daisuke Sato, Naoki Yoshinaga, Eiichi Nagai, Kazue Nagai, Eiji Shimizu. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 11.04.2019. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on http://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Sato, Daisuke
Yoshinaga, Naoki
Nagai, Eiichi
Nagai, Kazue
Shimizu, Eiji
Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial
title Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial
title_full Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial
title_fullStr Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial
title_full_unstemmed Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial
title_short Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial
title_sort effectiveness of internet-delivered computerized cognitive behavioral therapy for patients with insomnia who remain symptomatic following pharmacotherapy: randomized controlled exploratory trial
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482403/
https://www.ncbi.nlm.nih.gov/pubmed/30973344
http://dx.doi.org/10.2196/12686
work_keys_str_mv AT satodaisuke effectivenessofinternetdeliveredcomputerizedcognitivebehavioraltherapyforpatientswithinsomniawhoremainsymptomaticfollowingpharmacotherapyrandomizedcontrolledexploratorytrial
AT yoshinaganaoki effectivenessofinternetdeliveredcomputerizedcognitivebehavioraltherapyforpatientswithinsomniawhoremainsymptomaticfollowingpharmacotherapyrandomizedcontrolledexploratorytrial
AT nagaieiichi effectivenessofinternetdeliveredcomputerizedcognitivebehavioraltherapyforpatientswithinsomniawhoremainsymptomaticfollowingpharmacotherapyrandomizedcontrolledexploratorytrial
AT nagaikazue effectivenessofinternetdeliveredcomputerizedcognitivebehavioraltherapyforpatientswithinsomniawhoremainsymptomaticfollowingpharmacotherapyrandomizedcontrolledexploratorytrial
AT shimizueiji effectivenessofinternetdeliveredcomputerizedcognitivebehavioraltherapyforpatientswithinsomniawhoremainsymptomaticfollowingpharmacotherapyrandomizedcontrolledexploratorytrial